In human CRC patients, high expression of M2 makers ARG1 and MRC1 was significantly associated with poor survival, whereas high expression of the M1 marker NOS2 was significantly associated with good survival in the majority of ten analyzed CRC patient cohorts (Fig. S8D–F). This evidence concerns the gene MRC1 and colorectal carcinoma.